SELF-TEST FOR HUMAN CHORIONIC GONADOTROPIN (HCG) - ANVISA Registration 81325990268

Access comprehensive regulatory information for SELF-TEST FOR HUMAN CHORIONIC GONADOTROPIN (HCG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81325990268 and manufactured by ACRO BIOTECH, INC. (MONTCLAIR). The registration is held by QR CONSULTING, IMPORTACAO E DISTRIBUICAO DE PRODUTOS MEDICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, ALAMAR TECNO CIENTÍFICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81325990268
Registration Details
ANVISA Registration Number: 81325990268
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Família Teste Rápido de sensibilidade aprimorada de Gravidez por hCG em Bastão (Urina) com Indicador (para autoteste)
Risk Class II

Registration Details

81325990268

25351353543202372

19933144000129

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Jul 03, 2023

VIGENTE

09/18/2025 19:00:01